78 related articles for article (PubMed ID: 10560901)
1. Algorithm for the treatment of major depression in patients with advanced cancer.
Nakano T; Kugaya A; Akechi T; Mikami I; Okuyama T; Okamura H; Uchitomi Y
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S61-5. PubMed ID: 10560901
[TBL] [Abstract][Full Text] [Related]
2. Algorithms for the pharmacotherapy of major depression.
Shioe K; Kanba S
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S77-82. PubMed ID: 10560904
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Okamura M; Akizuki N; Nakano T; Shimizu K; Ito T; Akechi T; Uchitomi Y
Psychooncology; 2008 Feb; 17(2):154-60. PubMed ID: 17461435
[TBL] [Abstract][Full Text] [Related]
4. International consensus statement on major depressive disorder.
Nutt DJ; Davidson JR; Gelenberg AJ; Higuchi T; Kanba S; Karamustafalioğlu O; Papakostas GI; Sakamoto K; Terao T; Zhang M
J Clin Psychiatry; 2010; 71 Suppl E1():e08. PubMed ID: 20371035
[TBL] [Abstract][Full Text] [Related]
5. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
Trivedi MH; Lin EH; Katon WJ
CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
[TBL] [Abstract][Full Text] [Related]
6. Treating major depression: antidepressant algorithms.
Thase ME
J Clin Psychiatry; 2009 Dec; 70(12):e46. PubMed ID: 20141703
[TBL] [Abstract][Full Text] [Related]
7. Adherence to antidepressant treatment.
Hansen HV; Kessing LV
Expert Rev Neurother; 2007 Jan; 7(1):57-62. PubMed ID: 17187497
[TBL] [Abstract][Full Text] [Related]
8. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
Hamoda HM; Osser DN
Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
[TBL] [Abstract][Full Text] [Related]
9. [Depressive symptoms and the Idiopathic Parkinson's Syndrome (IPS): a review].
Giupponi G; Pycha R; Erfurth A; Hausmann A; Conca A
Neuropsychiatr; 2008; 22(2):71-82. PubMed ID: 18606109
[TBL] [Abstract][Full Text] [Related]
10. The Texas Medication Algorithm Project for major depression.
Ereshefsky L
Manag Care; 2001 Aug; 10(8 Suppl):16-7; discussion 18-22. PubMed ID: 11729434
[No Abstract] [Full Text] [Related]
11. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
Baune BT; Caliskan S; Todder D
Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
[TBL] [Abstract][Full Text] [Related]
12. Challenges and algorithm-guided treatment in major depressive disorder.
Shelton RC; Trivedi MH
J Clin Psychiatry; 2011 Apr; 72(4):e14. PubMed ID: 21527120
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.
Perahia DG; Quail D; Gandhi P; Walker DJ; Peveler RC
J Affect Disord; 2008 May; 108(1-2):33-41. PubMed ID: 17905442
[TBL] [Abstract][Full Text] [Related]
14. Algorithms in clinical psychiatry: a stepped approach toward the path to recovery.
Trivedi M
Psychopharmacol Bull; 2002; 36 Suppl 2():142-9. PubMed ID: 12490830
[TBL] [Abstract][Full Text] [Related]
15. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
16. Use of slow-release melatonin in treatment-resistant depression.
Dalton EJ; Rotondi D; Levitan RD; Kennedy SH; Brown GM
J Psychiatry Neurosci; 2000 Jan; 25(1):48-52. PubMed ID: 10721684
[TBL] [Abstract][Full Text] [Related]
17. Remission of depression and the Texas Medication Algorithm Project.
Trivedi MH
Manag Care Interface; 2003; Suppl B():9-13. PubMed ID: 12647607
[No Abstract] [Full Text] [Related]
18. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression.
Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
J Affect Disord; 2005 Feb; 84(2-3):141-7. PubMed ID: 15708411
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
20. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
